Title: Medetomidine
CAS Registry Number: 86347-14-0
CAS Name: 4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
Additional Names: (±)-4-(a,2,3-trimethylbenzyl)imidazole; 4-[(a-methyl)-2,3-dimethylbenzyl]imidazole
Molecular Formula: C13H16N2
Molecular Weight: 200.28
Percent Composition: C 77.96%, H 8.05%, N 13.99%
Literature References: a2-Adrenergic agonist. Prepn: A. J. Karjalainen et al., GB 2101114; A. J. Karjalainen, K. O. A. Kurkela, US 4544664 (1983, 1985 both to Farmos). Receptor binding study: R. Virtanen et al., Eur. J. Pharmacol. 150, 9 (1988). Sedative and cardiovascular effects in humans: M. Scheinin et al., Br. J. Clin. Pharmacol. 24, 443 (1987). Veterinary evaluation in cats: D. Stenberg et al., J. Vet. Pharmacol. Ther. 10, 319 (1987). Review of pharmacology and use in dogs and cats: L. K. Cullen, Br. Vet. J. 152, 519-535 (1996).
Derivative Type: Hydrochloride
CAS Registry Number: 86347-15-1
Manufacturers' Codes: MPV-785
Trademarks: Domitor (Pfizer)
Molecular Formula: C13H16CN2.HCl
Molecular Weight: 248.75
Percent Composition: C 67.60%, H 6.89%, N 11.26%, Cl 14.25%
Properties: White or almost white crystalline substance. Sol in water.
Derivative Type: d-Form see Dexmedetomidine
Therap-Cat-Vet: Sedative; analgesic.

Others monographs:
β-Resorcylic AcidValnoctamideNylidrinTetramethyldiaminobutane
MinaprineCyclizineQuinestradioln-Butylmalonic Acid
Cyanic AcidSuramin SodiumUrenaCitrullol
©2016 DrugLead US FDA&EMEA